Synceres Biosciences
PrivateLast Round
Series A
Extension
Jun 15, 2023
Total Funding Raised
$14.92M
Company Overview
Synceres Biosciences is a synthetic biology company that develops and produces bio-based ingredients for industries including biomedicine, health food, and industrial chemicals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synceres Biosciences Comparables
Compare Synceres Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbSci | 68% | |
| Abiochem Biotechnology | 56% | |
| GenScript | 55% |
Synceres Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 15, 2023 | ||||
| Series A | Mar 16, 2022 | ||||
| Angel | Oct 22, 2020 | ||||
| Pre Seed | Jul 24, 2019 |
Synceres Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bloomage International Group | Series A Extension |
| Tasly Holding Group | Series A Extension |
| Shenzhen New Henglida Capital Management | Pre Seed, Series A Extension |
| CoStone Capital | Series A Extension |
| Shenzhen HTI Group | Series A |
| Shenzhen Capital Group | Pre Seed, Angel, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2022
$15M round led by Shenzhen Capital Group
- Oct 22, 2020
Shenzhen Capital Group led the Angel round.
Synceres Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synceres Biosciences's valuation, stock price, and market status.
Is Synceres Biosciences a public or private company?
Synceres Biosciences is a private company.
What is the current stock price of Synceres Biosciences?
Synceres Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Synceres Biosciences worth (valuation)?
Valuation information for Synceres Biosciences is not publicly available.
Can I buy Synceres Biosciences stock?
Synceres Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synceres Biosciences's last funding round?
Synceres Biosciences's most recent funding round was Series A Extension on June 15, 2023.
Who are the main investors in Synceres Biosciences?
Key investors in Synceres Biosciences include Shenzhen Capital Group.
Will Synceres Biosciences IPO soon?
No public IPO plans have been announced for Synceres Biosciences.
How can I track Synceres Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synceres Biosciences's secondary market activity and sign up for updates.